Hypertension in pregnancy: diagnosis and management

severe hypertension or severe pre-eclampsia to the appropriate critical care setting using the criteria in table 4. [2010] Table 4 Clinical criteria for choice of critical care level Critical care level Clinical criteria Level 3 Severe pre-eclampsia and needing ventilation care Step-down from level 3 or severe pre-eclampsia with any of the following complications: • eclampsia • HELLP syndrome • haemorrhage • hyperkalaemia Level 2 • severe oliguria care • coagulation support • intravenous antihypertensive treatment • initial stabilisation of severe hypertension • evidence of cardiac failure • abnormal neurology Pre-eclampsia with hypertension Ongoing conservative antenatal management of severe preterm Level 1 care hypertension Step-down treatment after the birth 1.9 Antihypertensive treatment during the postnatal period, including during breastfeeding For the indications in recommendations 1.9.4, 1.9.6 and 1.9.8, in 2009, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug safety update on ACE inhibitors and angiotensin II receptor antagonists: recommendations on how to use during breastfeeding, and a subsequent clarification was issued in 2014 stating that 'although ACE inhibitors and angiotensin II receptor antagonists are generally not recommended for use by breastfeeding mothers, they are not absolutely contraindicated. Healthcare professionals may prescribe these medicines during breastfeeding if they
